BRCA1 and familial pancreatic carcinoma: Some tumors with inactivating mutations of BRCA1 or BRCA2, such as some breast and pancreatic cancers, have substantial numbers of larger deletions (up to 50 bp) with overlapping microhomology at breakpoint junctions [13,54].